Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-02-13

FDA Approved: GEFITINIB — Original Application (Ingenus Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved Ingenus Pharmaceuticals' original application for Gefitinib, establishing a generic version of the cancer drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gefitinib (Gefitinib)

Snippet

ORIG AP for GEFITINIB (GEFITINIB)